{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:46:26Z","timestamp":1764402386248},"reference-count":58,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.vaccine.2007.11.024","type":"journal-article","created":{"date-parts":[[2007,12,4]],"date-time":"2007-12-04T14:18:19Z","timestamp":1196777899000},"page":"978-987","source":"Crossref","is-referenced-by-count":16,"title":["Phase 1 clinical trial of live attenuated Shigella dysenteriae type-1 \u0394icsA \u0394ent \u0394fep \u0394stxA:HgR oral vaccine SC599 in healthy human adult volunteers"],"prefix":"10.1016","volume":"26","author":[{"given":"Christine","family":"Sadorge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Ndiaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Beveridge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Schale","family":"Frazer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafaela","family":"Giemza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Jolly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Liddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine A.","family":"Cosgrove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Allavena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"B\u00e9chet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annick","family":"Fontaine-Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George E.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe J.","family":"Sansonetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.M.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.vaccine.2007.11.024_bib1","first-page":"651","article-title":"Global burden of Shigella infections: implications for vaccine development and implementation of control strategies","volume":"77","author":"Kotloff","year":"1999","journal-title":"Bull World Health Organ"},{"issue":"1","key":"10.1016\/j.vaccine.2007.11.024_bib2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1471-2334-5-89","article-title":"The burden of diarrhoea, shigellosis, and cholera in Jakarta, Indonesia","volume":"5","author":"Agtini","year":"2005","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2007.11.024_bib3","doi-asserted-by":"crossref","first-page":"416","DOI":"10.4269\/ajtmh.2005.73.416","article-title":"Occurrence of shigellosis in the young and elderly in rural China: results of a 12-month population-based surveillance study","volume":"73","author":"Wang","year":"2005","journal-title":"Am J Trop Med Hyg"},{"issue":"Suppl. 4","key":"10.1016\/j.vaccine.2007.11.024_bib4","doi-asserted-by":"crossref","first-page":"S245","DOI":"10.1093\/clinids\/13.Supplement_4.S245","article-title":"Mortality due to shigellosis: community and hospital data","volume":"13","author":"Bennish","year":"1991","journal-title":"Rev Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2007.11.024_bib5","first-page":"313","article-title":"Assessing the cause of in-patients pediatric diarrheal deaths: an analysis of hospital records","volume":"32","author":"Dutta","year":"1995","journal-title":"Indian Pediatr"},{"issue":"6","key":"10.1016\/j.vaccine.2007.11.024_bib6","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1046\/j.1365-3156.1999.00413.x","article-title":"Risk factors for death in hospitalized dysentery patients in Rwanda","volume":"4","author":"Legros","year":"1999","journal-title":"Trop Med Int Health"},{"issue":"9385","key":"10.1016\/j.vaccine.2007.11.024_bib7","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0140-6736(03)14227-4","article-title":"Shigella dysenteriae serotype 1 in west Africa: intervention strategy for an outbreak in Sierra Leone","volume":"362","author":"Guerin","year":"2003","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2007.11.024_bib8","first-page":"787","article-title":"Epidemic dysentery caused by Shigella dysenteriae type 1: a sentinel site surveillance of antimicrobial resistance patterns in Burundi","volume":"73","author":"Engels","year":"1995","journal-title":"Bull World Health Organ"},{"issue":"5","key":"10.1016\/j.vaccine.2007.11.024_bib9","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/tropej\/41.5.281","article-title":"Epidemic Shigella dysenteriae type 1 in Natal","volume":"41","author":"Rollins","year":"1995","journal-title":"J Trop Pediatr"},{"issue":"5","key":"10.1016\/j.vaccine.2007.11.024_bib10","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/infdis\/169.5.1035","article-title":"Epidemic Shigella dysenteriae type 1 in Burundi: panresistance and implications for prevention","volume":"169","author":"Ries","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.11.024_bib11","unstructured":"Health status of displaced persons following Civil War\u2013Burundi, December 1993\u2013January 1994. MMWR Morb Mortal Wkly Rep 1994;43(38):701\u20133."},{"issue":"3","key":"10.1016\/j.vaccine.2007.11.024_bib12","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/infdis\/122.3.170","article-title":"Epidemic Shiga bacillus dysentery in Central America. I. Etiologic investigations in Guatemala, 1969","volume":"122","author":"Mata","year":"1970","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2007.11.024_bib13","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/clinids\/14.5.1055","article-title":"Antimicrobial resistance of Shigella isolates in Bangladesh, 1983\u20131990: increasing frequency of strains multiply resistant to ampicillin, trimethoprim\u2013sulfamethoxazole, and nalidixic acid","volume":"14","author":"Bennish","year":"1992","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2007.11.024_bib14","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1128\/AAC.48.2.681-684.2004","article-title":"Clonal multidrug-resistant Shigella dysenteriae type 1 strains associated with epidemic and sporadic dysenteries in eastern India","volume":"48","author":"Pazhani","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.vaccine.2007.11.024_bib15","first-page":"33","article-title":"Multiresistant Shigella species isolated from childhood diarrhea cases in Kolkata, India","volume":"56","author":"Niyogi","year":"2003","journal-title":"Jpn J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2007.11.024_bib16","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.3201\/eid0911.020652","article-title":"Shigella dysenteriae serotype 1, Kolkata","volume":"9","author":"Dutta","year":"2003","journal-title":"India. Emerg Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2007.11.024_bib17","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1473-3099(04)01143-0","article-title":"Fluoroquinolone-resistant Shigella dysenteriae type 1 in northeastern Bangladesh","volume":"4","author":"Naheed","year":"2004","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2007.11.024_bib18","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0749-3797(18)30902-4","article-title":"Evaluation of an intervention program in the control of an urban outbreak of shigellosis","volume":"7","author":"Mahoney","year":"1991","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.vaccine.2007.11.024_bib19","doi-asserted-by":"crossref","unstructured":"Public health impact of Rwandan refugee crisis: what happened in Goma, Zaire, in July, 1994? Goma Epidemiology Group. Lancet 1995;345(8946):339\u201344.","DOI":"10.1016\/S0140-6736(95)90338-0"},{"issue":"21","key":"10.1016\/j.vaccine.2007.11.024_bib20","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1016\/j.vaccine.2004.11.044","article-title":"Policymakers\u2019 views regarding the introduction of new-generation vaccines against typhoid fever, shigellosis and cholera in Asia","volume":"23","author":"DeRoeck","year":"2005","journal-title":"Vaccine"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2007.11.024_bib21","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/0923-2508(90)90129-E","article-title":"Construction and evaluation of live attenuated vaccine strains of Shigella flexneri and Shigella dysenteriae 1","volume":"141","author":"Fontaine","year":"1990","journal-title":"Res Microbiol"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2007.11.024_bib22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0378-1119(87)90127-2","article-title":"An nptI-sacB-sacR cartridge for constructing directed, unmarked mutations in gram-negative bacteria by marker exchange-eviction mutagenesis","volume":"57","author":"Ried","year":"1987","journal-title":"Gene"},{"issue":"6","key":"10.1016\/j.vaccine.2007.11.024_bib23","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1128\/jb.170.6.2575-2583.1988","article-title":"A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR","volume":"170","author":"Miller","year":"1988","journal-title":"J Bacteriol"},{"issue":"19","key":"10.1016\/j.vaccine.2007.11.024_bib24","doi-asserted-by":"crossref","first-page":"6957","DOI":"10.1128\/JB.00621-07","article-title":"Anaerobic regulation of Shigella flexneri virulence: ArcA regulates Fur and iron acquisition genes","volume":"189","author":"Boulette","year":"2007","journal-title":"J Bacteriol"},{"issue":"5","key":"10.1016\/j.vaccine.2007.11.024_bib25","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1046\/j.1365-2958.1999.01669.x","article-title":"Spontaneous tandem amplification and deletion of the shiga toxin operon in Shigella dysenteriae 1","volume":"34","author":"McDonough","year":"1999","journal-title":"Mol Microbiol"},{"issue":"7","key":"10.1016\/j.vaccine.2007.11.024_bib26","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1097\/00003246-200107000-00017","article-title":"Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients","volume":"29","author":"Muller","year":"2001","journal-title":"Crit Care Med"},{"issue":"9","key":"10.1016\/j.vaccine.2007.11.024_bib27","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1002\/eji.1830210917","article-title":"The early cellular and humoral immune response to primary and booster oral immunization with cholera toxin B subunit","volume":"21","author":"Lewis","year":"1991","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2007.11.024_bib28","series-title":"Manual of clinical immunology","first-page":"388","article-title":"Serological response to Bordatella pertussis","author":"Manclark","year":"1986"},{"issue":"3","key":"10.1016\/j.vaccine.2007.11.024_bib29","first-page":"375","article-title":"Studies on vaccination against bacillary dysentery. 4. Oral immunization with live monotypic and combined vaccines","volume":"39","author":"Mel","year":"1968","journal-title":"Bull World Health Organ"},{"issue":"1","key":"10.1016\/j.vaccine.2007.11.024_bib30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/infdis\/125.1.12","article-title":"Immunity in shigellosis. II. Protection induced by oral live vaccine or primary infection","volume":"125","author":"DuPont","year":"1972","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2007.11.024_bib31","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/01.inf.0000078156.03697.a5","article-title":"Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children","volume":"22","author":"Passwell","year":"2003","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"10.1016\/j.vaccine.2007.11.024_bib32","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1128\/IAI.61.9.3678-3687.1993","article-title":"Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids","volume":"61","author":"Taylor","year":"1993","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2007.11.024_bib33","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1128\/IAI.64.10.4074-4077.1996","article-title":"Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteers","volume":"64","author":"Cohen","year":"1996","journal-title":"Infect Immun"},{"issue":"9046","key":"10.1016\/j.vaccine.2007.11.024_bib34","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(96)06255-1","article-title":"Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults","volume":"349","author":"Cohen","year":"1997","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2007.11.024_bib35","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0264-410X(91)90308-S","article-title":"Construction of aromatic dependent Shigella flexneri 2a live vaccine candidate strains: deletion mutations in the aroA and the aroD genes","volume":"9","author":"Verma","year":"1991","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2007.11.024_bib36","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1128\/IAI.72.2.923-930.2004","article-title":"Two studies evaluating the safety and immunogenicity of a live, attenuated Shigella flexneri 2a vaccine (SC602) and excretion of vaccine organisms in North American volunteers","volume":"72","author":"Katz","year":"2004","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2007.11.024_bib37","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1128\/IAI.64.11.4542-4548.1996","article-title":"Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG","volume":"64","author":"Kotloff","year":"1996","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2007.11.024_bib38","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1128\/IAI.64.8.3055-3061.1996","article-title":"Engineered deltaguaB-A deltavirG Shigella flexneri 2a strain CVD 1205: construction, safety, immunogenicity, and potential efficacy as a mucosal vaccine","volume":"64","author":"Noriega","year":"1996","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2007.11.024_bib39","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.1128\/IAI.62.11.5168-5172.1994","article-title":"Construction and characterization of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine","volume":"62","author":"Noriega","year":"1994","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2007.11.024_bib40","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/0264-410X(91)90064-D","article-title":"Virulence phenotype and genetic characteristics of the T32-ISTRATI Shigella flexneri 2a vaccine strain","volume":"9","author":"Venkatesan","year":"1991","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2007.11.024_bib41","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1128\/IAI.70.6.2950-2958.2002","article-title":"Construction, characterization, and animal testing of WRSd1, a Shigella dysenteriae 1 vaccine","volume":"70","author":"Venkatesan","year":"2002","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2007.11.024_bib42","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1128\/IAI.66.9.4572-4576.1998","article-title":"Construction of a stable attenuated Shigella sonnei DeltavirG vaccine strain, WRSS1, and protective efficacy and immunogenicity in the guinea pig keratoconjunctivitis model","volume":"66","author":"Hartman","year":"1998","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2007.11.024_bib43","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1128\/IAI.70.4.2016-2021.2002","article-title":"Phase I evaluation of delta virG Shigella sonnei live, attenuated, oral vaccine strain WRSS1 in healthy adults","volume":"70","author":"Kotloff","year":"2002","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2007.11.024_bib44","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0264-410X(94)00011-B","article-title":"Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli\u2013Shigella flexneri 2a vaccine strain EcSf2a-2","volume":"13","author":"Kotloff","year":"1995","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2007.11.024_bib45","first-page":"457","article-title":"Studies on vaccination against bacillary dysentery. 6. Protection of children by oral immunization with streptomycin-dependent Shigella strains","volume":"45","author":"Mel","year":"1971","journal-title":"Bull World Health Organ"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2007.11.024_bib46","first-page":"109","article-title":"Live oral Shigella vaccine: vaccination schedule and the effect of booster dose","volume":"21","author":"Mel","year":"1974","journal-title":"Acta Microbiol Acad Sci Hung"},{"issue":"5","key":"10.1016\/j.vaccine.2007.11.024_bib47","first-page":"647","article-title":"Studies on vaccination against bacillary dysentery. 3. Effective oral immunization against Shigella flexneri 2a in a field trial","volume":"32","author":"Mel","year":"1965","journal-title":"Bull World Health Organ"},{"issue":"11","key":"10.1016\/j.vaccine.2007.11.024_bib48","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/0264-410X(96)00006-0","article-title":"Cross-reactivity of Shigella flexneri serotype 2a O antigen antibodies following immunization or infection","volume":"14","author":"Van De Verg","year":"1996","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2007.11.024_bib49","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1128\/IAI.67.2.782-788.1999","article-title":"Strategy for cross-protection among Shigella flexneri serotypes","volume":"67","author":"Noriega","year":"1999","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2007.11.024_bib50","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1128\/IAI.68.3.1034-1039.2000","article-title":"Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans","volume":"68","author":"Kotloff","year":"2000","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2007.11.024_bib51","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.4049\/jimmunol.164.4.2221","article-title":"Production of IFN-gamma and IL-10 to Shigella invasins by mononuclear cells from volunteers orally inoculated with a Shiga toxin-deleted Shigella dysenteriae type 1 strain","volume":"164","author":"Samandari","year":"2000","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2007.11.024_bib52","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1128\/IAI.67.7.3437-3443.1999","article-title":"Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602","volume":"67","author":"Coster","year":"1999","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2007.11.024_bib53","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0264-410X(90)90088-4","article-title":"Antibody-secreting cells in the evaluation of the immunogenicity of an oral vaccine","volume":"8","author":"Kantele","year":"1990","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2007.11.024_bib54","doi-asserted-by":"crossref","first-page":"8027","DOI":"10.1128\/IAI.73.12.8027-8032.2005","article-title":"Community-based safety, immunogenicity, and transmissibility study of the Shigella sonnei WRSS1 vaccine in Israeli volunteers","volume":"73","author":"Orr","year":"2005","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2007.11.024_bib55","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nri1499","article-title":"War and peace at mucosal surfaces","volume":"4","author":"Sansonetti","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2007.11.024_bib56","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1128\/IAI.70.7.3457-3467.2002","article-title":"Characterization of Salmonella enterica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers","volume":"70","author":"Hindle","year":"2002","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2007.11.024_bib57","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.coi.2005.11.009","article-title":"Pentraxins as a key component of innate immunity","volume":"18","author":"Bottazzi","year":"2006","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.11.024_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.micinf.2004.09.004","article-title":"IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection","volume":"7","author":"Azzurri","year":"2005","journal-title":"Microbes Infect"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07013175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07013175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T03:56:42Z","timestamp":1588132602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07013175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":58,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0264410X07013175"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.11.024","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}